Kristy Ainslie/pharmacy.unc.edu
Mar 6, 2026, 15:43
Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
Kristy Ainslie, Fred Eshelman Distinguished Professor and Director at University of North Carolina at Chapel Hill, shared a post on LinkedIn:
“Ever wonder about the discovery and FDA approval of your favorite drug carrier? I’ve broken them down and highlighted each advancement – with references!
Enjoy and let me know if think I forgot something.
Part 1 – Living Medicine
Part 2 – Complex Biologics
Part 3 – Inorganic Carriers
Part 4 – Other Carriers
Part 5 – Nucleic Acids and Lipids
Part 6 – Polymers
Part 7 – Proteins
Part 8 – Devices”
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care
-
Jun 24, 2026, 07:46Wolfgang Miesbach: WFH’s First AAV Gene Therapy Chapter Marks a New Era in Hemophilia Care
-
Jun 24, 2026, 06:42Deepthi Krishna: World Blood Donor Day 2026 Celebrations at Rela Hospital
-
Jun 24, 2026, 03:36Ana Pedrero Gil: A New Approach to Post-Tonsillectomy Hemorrhage
-
Jun 24, 2026, 02:59Melissa Hollo: Making Early Anemia Detection the Standard of Care
-
Jun 24, 2026, 02:51Bruno Pougault: The Thin Line Between Bleeding and Clotting
-
Jun 23, 2026, 23:30Shunsuke Iwano: PMDA Introduces Greater Flexibility for Pediatric Factor VIII and IX Development in Japan
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI